Pierre Heimendinger
Corporate Officer/Principal chez TXCELL
Profil
Pierre Heimendinger is currently the Vice President-Process Development at Sangamo Therapeutics France SAS.
He holds a doctorate degree from Université Paris Diderot-Paris 7.
Postes actifs de Pierre Heimendinger
| Sociétés | Poste | Début |
|---|---|---|
| TXCELL | Corporate Officer/Principal | - |
Formation de Pierre Heimendinger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
| Université Paris Diderot-Paris 7 | Consumer Services |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS Pharmaceuticals: MajorHealth Technology Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Health Technology |
